Home › Compare › CRFTF vs JNJ

CRFTF vs JNJ: Dividend Comparison 2026

CRFTF yields 20000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRFTF wins by $4.875981653489057e+49M in total portfolio value
10 years
CRFTF
CRFTF
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full CRFTF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CRFTF vs JNJ

📍 CRFTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRFTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRFTF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CRFTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRFTF
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CRFTF beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRFTF + JNJ for your $10,000?

CRFTF: 50%JNJ: 50%
100% JNJ50/50100% CRFTF
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CRFTF
No analyst data
Altman Z
-893.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRFTF buys
0
JNJ buys
0
No recent congressional trades found for CRFTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRFTFJNJ
Forward yield20000000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.875981653489057e+49M$20.0K ✓
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.875978515990276e+49M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRFTF vs JNJ ($10,000, DRIP)

YearCRFTF PortfolioCRFTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$10,676$355.77+$2000.00M → CRFTF
2$373,835,915,712,384$373,833,775,700,934.50$11,407$389.39+$373835915.70M → CRFTF
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$12,198$426.53+$65304953364964.96M → CRFTF
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$13,056$467.62+$10661728832755499008.00M → CRFTF
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$13,987$513.12+$1.626767783781495e+24M → CRFTF
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$14,998$563.56+$2.319743300546251e+29M → CRFTF
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$16,098$619.52+$3.0915106403922057e+34M → CRFTF
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$17,295$681.69+$3.8505079858392777e+39M → CRFTF
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$18,599$750.82+$4.4821026103531426e+44M → CRFTF
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.875981653489057e+49M → CRFTF

CRFTF vs JNJ: Complete Analysis 2026

CRFTF — Stock

BC Craft Supply Co. Ltd. operates as a diversified life sciences company advancing cannabinoid and psychedelic innovation and psychotherapy. Its operations include CRFT, a curator and aggregator of craft cannabis, providing advocacy and access for premium small-batch growers to Canada's cannabis market; Medcann Health Products, a cultivation and processing facility in Chemainus providing access to Canadian medical and recreational cannabis markets; Feelwell Brands, a cannabinoid brand house licensed in the state of California; and AVA Pathways, a pre-clinical biotech company focuses on neuroplasticity and mental health applications using psilocybin and compounds derived from mushrooms. The company was formerly known as Pasha Brands Ltd. and changed its name to BC Craft Supply Co. Ltd. in May 2020. BC Craft Supply Co. Ltd. is based in Vancouver, Canada.

Full CRFTF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CRFTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRFTF vs SCHDCRFTF vs JEPICRFTF vs OCRFTF vs KOCRFTF vs MAINCRFTF vs ABBVCRFTF vs MRKCRFTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.